ArticleEuropean journal of nuclear medicine and molecular imaging2014
Peptide receptor radionuclide therapy for neuroendocrine tumours: standardized and randomized, or personalized?
Article in European journal of nuclear medicine and molecular imaging, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Long-Term Follow-up and Outcomes of Retreatment in an Expanded 50-Patient Single-Center Phase II Prospective Trial ofJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2020Trial
- Trial
- High clinical and morphologic response usingEuropean journal of nuclear medicine and molecular imaging · 2017Trial
- Tumor sink effect on melanin-ligand [EJNMMI research · 2025Article
- Article
- Tumor Sink Effect inJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2022Article
- Practical kidney dosimetry in peptide receptor radionuclide therapy using [EJNMMI physics · 2021Article
- Theranostic implications of molecular imaging phenotype of well-differentiated pulmonary carcinoid based onEuropean journal of nuclear medicine and molecular imaging · 2021Article
- Enhancing the anti-tumour activity ofScientific reports · 2020Article
- Peptide Receptor Radiotherapy: Current Approaches and Future Directions.Current treatment options in oncology · 2019Review
- Peptide receptor radionuclide therapy (PRRT) in European Neuroendocrine Tumour Society (ENETS) grade 3 (G3) neuroendocrine neoplasia (NEN) - a single-institution retrospective analysis.European journal of nuclear medicine and molecular imaging · 2018Article
- Most medical practices are not parachutes: a citation analysis of practices felt by biomedical authors to be analogous to parachutes.CMAJ open · 2018Article
- The difference between medicine and magic is that magicians know what they are doing.European journal of nuclear medicine and molecular imaging · 2015Article
- Lutetium-177 DOTATATE Production with an Automated Radiopharmaceutical Synthesis System.Asia Oceania journal of nuclear medicine & biology · 2015Article
Corrections and comments
- Comment on
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
24221244What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.